Mobile health (mHealth) is an area of electronic health (eHealth) that delivers revolutionized healthcare services through mobile technologies such as mobile phones that enable the remote monitoring of patients suffering from acute and chronic diseases. The growing prevalence of lifestyle diseases such as diabetes, obesity, hypertension, chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA), creates an impending need for technologically advanced platforms for the prevention and treatment of these diseases. According to the World Health Organization (WHO), an estimate of 3.1 million deaths occurred due to COPD in 2012, which accounted for about 5.6% of the global death toll. In 2012, nearly 6.7 million deaths occurred due to CVD stroke which accounted for about 11.9% of the global death toll. The frequent launch of smartphone based medical devices such as cardiac monitors, respiratory monitors and blood glucose monitors address the need for regular health monitoring and treatment of diseases.
The global mHealth market was evaluated at $10.5 billion in 2014, and is expected to register a high CAGR of 33.5% during the forecast period (2015 to 2020). This growth would be primarily driven by the growing prevalence of lifestyle diseases, active government initiatives and the rising adoption of smartphones, globally. Presently, the market is witnessing a resurgence due to the increased mobile penetration, which is more than 100% in developed markets. A similar trend is observed in the developing markets, namely the Asia-Pacific and Africa. The lower accuracy and the nascence of technologies, especially in developing and under-developed regions are major factors that limit the growth of the mHealth market.
The global mHealth market is segmented into devices, services, application, stakeholders and geography. Based on device type, the market is further segmented into blood glucose meters, BP monitors, pulse oximetry, neurological monitoring devices, apnea and sleep monitors, wearable fitness sensor device & heart rate meters and others. BP monitors segment holds a dominant share; however, the blood glucose meters segment is estimated to register the fastest growth in the global mHealth devices market. Factors such as rising incidences of hypertension, sedentary lifestyles, the increasing count of diabetics, supplement the adoption of mHealth devices globally. Based on services, the market is segmented into diagnosis services, monitoring services, prevention, treatment and wellness & healthcare system strengthening solutions. Monitoring services segment holds a dominant share in the global mHealth services market and would register the highest CAGR through the forecast period (2015-2020). Based on stake holders, the market is segmented into mobile operators, device vendors, healthcare providers and application players/developers. Mobile operators segment occupies a dominant share in the global mHealth stakeholders market; whereas, the mobile application developers segment would register the highest CAGR during the forecast period (2015-2020). Based on applications, the mHealth market is segmented into cardiovascular diseases, diabetes, respiratory diseases, neurological diseases and others. The cardiovascular diseases segment holds a dominant share in the global mHealth applications market; however, the diabetes application segment is expected to register the highest CAGR during the forecast period (2015-2020). Based on geography, the market is segmented across North America, Europe, Asia-Pacific and LAMEA. North America region holds the largest share; whereas, Asia Pacific would be the fastest growing region in the global mHealth market.
The key players profiled in this report include - Philips Healthcare, Omron HealthCare, Inc., Bayer Healthcare, LifeWatch AG, Masimo Corporation, Sanofi S.A., Boston Scientific Corporation, AT&T Inc. and Johnson & Johnson. Product launch and collaboration are some of the key strategies adopted by companies operating in the global mHealth market. For example, in January 2015, Masimo Corporation launched MightySat, a Fingertip Pulse Oximeter with Masimo SET Measure-through Motion and Low Perfusion Technology. In March 2015, Omron launched its smartphone enabled activity tracker and fitness app.
KEY MARKET BENEFITS:
The report covers a quantitative analysis of the current market scenario and estimations through 2014-2020, which would enable the stakeholders to capitalize on prevailing market opportunities
The mHealth market scenario is comprehensively analysed based on key regions
The report profiles the prominent market players and highlights their key strategies, which helps in understanding the competitive outlook of the market
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework
Comprehensive analysis of factors that drive and restrict the growth of the global mHealth market is provided in the report
Exhaustive analysis of the global mHealth market, by device type, helps in understanding the types of devices that are presently used, along with the variants that would gain prominence in future
KEY MARKET SEGMENTS:
Global mHealth Market- By Devices
Blood glucose meters
Neurological monitoring devices
Apnea and sleep monitors
Wearable fitness sensor device & heart rate meters
Global mHealth Market- By Services
Wellness and healthcare system strengthening solutions
Global mHealth Market- By Stakeholders
Global mHealth Market- By Application
Global mHealth Market- By Geography
Rest of Europe
Rest of Asia-pacific
The Global Fetal Bovine Serum market size will be XX million (USD) in 2023, from the XX million (USD) in 2017, with a CAGR (Compound Annual Growth Rate) of XX% from between 2017 and 2023. This report studies the global Fetal Bovine Serum market, especially in North America, Europe, Asia-Pacific, South ...
March 2018 | $4960 |View Details>>
The Global Intrauterine Devices market size will be XX million (USD) in 2023, from the XX million (USD) in 2017, with a CAGR (Compound Annual Growth Rate) of XX% from between 2017 and 2023. This report studies the global Intrauterine Devices market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
March 2018 | $4960 |View Details>>
In 2017, the Fetal Bovine Serum market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In China market, the top players include Life Technologies Thermo Fisher ...
March 2018 | $3360 |View Details>>
In 2017, the Intrauterine Devices market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In China market, the top players include Bayer Merck Teva Pharmaceutical ...
March 2018 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2018 © Copyright Big Market Research